🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

David Palma, MD, PhD So excited to open INSPIRE! How low can we go?

Out now in Academic Medicine: We found race/ethnicity was a significant factor in faculty assessment of resident performance. Our study has generated conversation so let's review the study... bit.ly/3LzXUBD

This cause is close to my heart - please sign: sign.moveon.org/petitions/tell…

Over the last two decades, more school-age children have died from guns than on-duty police officers and active duty military combined. Think about that. For God’s sake how much more carnage are we willing to accept?

I remember breaking down to my Ph.D. advisor about how stupid I felt while troubleshooting a problem in my project when she handed me this paper. Years later it is still relevant to young students starting off in Science. It's ok to feel stupid, we all do on a regular basis.

Preprint from PDAC Stromal Reprogramming Consortium site Mass General Cancer Center (Dr. Rakesh Jain et al) with The Pittet Lab Addition of losartan to FOLFORINOX and chemoradiation downregulates pro-invasion and immunosuppression-associated genes in locally advanced #PancreaticCancer medrxiv.org/content/10.110…

🚨OncoAlert: #RadOnc is "constantly working to improve survival & patient well-being, form deep connections with our pts, & push the boundaries of medical innovations." Proud of this Medscape column w/ Dr Fantine Giap discussing what makes #radonc unique medscape.com/viewarticle/97…

Pancreatic cancer remains one of the most challenging cancers to fight. But improvements in a long-standing procedure are helping doctors chip away at it. Hear from Dr. Sanjay S. Reddy on how FCCC is treating pancreatic cancer in new ways: 6abc.cm/3QRS9mS 6abcaction

Researchers at Fox Chase have shown in a recent study that taking a new approach to targeting a well-established cancer-promoting pathway may be effective in stopping the progression of certain cancers. Read more about this study: bit.ly/3Op6buz

Temple University is tapping North Philly community members to help choose its medical students. What a great idea and fantastic use of the wonderful resource that is the Temple community! inquirer.com/news/temple-un…

Deeply saddened by the passing of Herman Suit, the great father figure of the Department of Radiation Oncology MassGeneral News, and one of the colossi of American oncology. bit.ly/3bLeEKs

We’re hiring for an outstanding opportunity as PI of a lab with appointments in Rad Onc and the Institute for Cancer Research at Fox Chase. Exciting collaborative atmosphere with resources and support. Please share and contact me with questions. careers.cell.com/job/10028/asst…

Boom!

ChatGPT tech could revolutionize healthcare!!! BUT what are its current shortcomings and potential DANGERS??? 🧵

Michael Chuong Miami Cancer Institute Research ViewRay Excellent! LC and QoL! like killing two birds with one stone!

Doctors at a major US insurance company deny tens of thousands of claims a month without even looking at patients’ files. “We literally click & submit,” a former Cigna doctor told @ProPublica & The Capitol Forum. “It takes all of 10 seconds to do 50 at a time.” The inside story 🧵

The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement regarding the PROSPECT clinical trial for patients with rectal cancer: astro.org/News-and-Publi…

This type of marketing of protons doesn't instill confidence in our field IMO. The site is aptly titled askforprotons.com On it, there is a quiz w 4 questions (age, prior RT, tumor site), but no matter what answers you put, it tells you protons may be needed.

Thanks to ESTRO for providing important context to the PROSPECT study.